INBIOGEN Co., Ltd. (KRX:101140)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,030.00
-320.00 (-5.98%)
At close: Aug 3, 2026

INBIOGEN Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-18,128-1,41916,12211,344-117,21894,125
Depreciation & Amortization
241.84363.491,0571,2241,4381,117
Loss (Gain) From Sale of Assets
-0.97-61.39168.1465.35-138.43
Asset Writedown & Restructuring Costs
1,0521,052992.37---
Loss (Gain) From Sale of Investments
-39.33-30.651.04-39,032178,976-123,863
Loss (Gain) on Equity Investments
14,026-2,979-21,53832,458-42,7775,062
Provision & Write-off of Bad Debts
55.6641.93146.46129.11-73.23361.64
Other Operating Activities
-106.32-18.8546.74-8,551-29,52718,627
Change in Accounts Receivable
-686.7-1,701-115.22,5831,718-2,088
Change in Inventory
94.8381.166.65-605.69-835.19-450.99
Change in Accounts Payable
-166.6-422.67218.13-233.19-412.39-60.71
Change in Other Net Operating Assets
-636.17-461.642,301-432.25-2,794-37.39
Operating Cash Flow
-4,293-5,554-33.13-1,051-11,505-7,069
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-10.1-42.5-84.28-25.96-130.68-2,360
Sale of Property, Plant & Equipment
164.9810.0573.8129.844.6
Sale (Purchase) of Intangibles
-46.11---305-200-41.15
Investment in Securities
---64.43-15,664-38,000
Other Investing Activities
444444000-
Investing Cash Flow
388.79466.48-74.23-192.72-15,925-40,437

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-500---15,000
Total Debt Issued
3,500500---15,000
Long-Term Debt Repaid
--227.03-265.3-1,895-28,432-777.72
Total Debt Repaid
-211.09-227.03-265.3-1,895-28,432-777.72
Net Debt Issued (Repaid)
3,289272.97-265.3-1,895-28,43214,222
Issuance of Common Stock
----12,000-
Repurchase of Common Stock
----62.49--
Other Financing Activities
-0-0--0--0
Financing Cash Flow
3,289272.97-265.3-1,95713,56861,543

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
00-0-0--0
Net Cash Flow
-615.51-4,815-372.65-3,201-13,86214,038

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-4,303-5,597-117.41-1,077-11,636-9,430
Free Cash Flow Growth
------
Free Cash Flow Margin
-79.05%-88.88%-1.67%-17.25%-111.67%-89.97%
Free Cash Flow Per Share
---11.76-126.51-3209.03-3155.62
Levered Free Cash Flow
-3,104-4,061-1,145-1,660-16,530-8,817
Unlevered Free Cash Flow
-3,038-4,012-1,113-1,496-14,226-6,423

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
119.9673.450.0310.7142.04220.28
Cash Income Tax Paid
--0.39-0.26-11.31.41-13.53
Change in Working Capital
-1,395-2,5042,4711,312-2,324-2,637